<p><b>(</b>A & B) AGS cells were treated with metformin for 24 hours and the cell invasion was measured in the Culturex 96 well BME invasion assay kit by counting the number of cells invading underside of BME (*<i>p</i> ≤ 0.01, **<i>p</i> ≤ 0.001 and ***<i>p</i> ≤ 0.0001). (C) Effect of high- and low-glucose media on cell invasion analyzed by JMP and levels not connected by same letter are significantly different (<i>p</i> ≤ 0.05).</p
<p>(A) MDA-MB-231 cells were treated with 5 mM metformin and 600 μM 2-DG in low-glucose (1 g/L) RPMI...
Cancer cells exhibit altered metabolism, a phenomenon described a century ago by Otto Warburg. Howev...
<p><b><i>A</i></b>, Single-cell suspensions of PANC-1 cells were plated at a density of 10<sup>5</su...
<p>MDAMB231 (<b>A</b>) and (<b>B</b>) MCF7 cells were treated with metformin (8 mM) in either 25 mM ...
<p><b>A.</b> MCF7 cells were treated with metformin (8 mM) for 15 hours in either 25 mM or 2.5 mM gl...
<p>MCF7 and MDAMB231 cells were treated with metformin in DMEM containing either 25 mM glucose or 2....
<p>All cells were treated with different concentrations of metformin (0, 2, 4, 8, 16 mM) in medium c...
Different cancer cells exhibit altered sensitivity to metformin treatment. Recent studies suggest th...
<p>MCF7, SKBR3 and MDA-MB-231 cells were plated at 8X10<sup>5</sup> cells/well in 6-well plates in M...
<p>(A) The cells were treated with metformin for 72 hours in two glucose concentrations and the desi...
<p>MCF7 cells were treated with metformin (8 mM) in medium containing 25 mM glucose, 25 mM fructose ...
<p><b>A.</b> After 48 hour treatments with metformin (5 mM, +) or control vehicle (H<sub>2</sub>O, –...
Epithelial-mesenchymal transition (EMT), which is mainly recognized by upregulation of mesenchymal m...
<p>Cells were exposed to medium with glucose concentrations varying from 5.5 to 50 mM for 12, 24, or...
<p>MCF7 (<b>A</b>) and MDAMB231 (<b>B</b>) cells were treated with metformin in DMEM without glucose...
<p>(A) MDA-MB-231 cells were treated with 5 mM metformin and 600 μM 2-DG in low-glucose (1 g/L) RPMI...
Cancer cells exhibit altered metabolism, a phenomenon described a century ago by Otto Warburg. Howev...
<p><b><i>A</i></b>, Single-cell suspensions of PANC-1 cells were plated at a density of 10<sup>5</su...
<p>MDAMB231 (<b>A</b>) and (<b>B</b>) MCF7 cells were treated with metformin (8 mM) in either 25 mM ...
<p><b>A.</b> MCF7 cells were treated with metformin (8 mM) for 15 hours in either 25 mM or 2.5 mM gl...
<p>MCF7 and MDAMB231 cells were treated with metformin in DMEM containing either 25 mM glucose or 2....
<p>All cells were treated with different concentrations of metformin (0, 2, 4, 8, 16 mM) in medium c...
Different cancer cells exhibit altered sensitivity to metformin treatment. Recent studies suggest th...
<p>MCF7, SKBR3 and MDA-MB-231 cells were plated at 8X10<sup>5</sup> cells/well in 6-well plates in M...
<p>(A) The cells were treated with metformin for 72 hours in two glucose concentrations and the desi...
<p>MCF7 cells were treated with metformin (8 mM) in medium containing 25 mM glucose, 25 mM fructose ...
<p><b>A.</b> After 48 hour treatments with metformin (5 mM, +) or control vehicle (H<sub>2</sub>O, –...
Epithelial-mesenchymal transition (EMT), which is mainly recognized by upregulation of mesenchymal m...
<p>Cells were exposed to medium with glucose concentrations varying from 5.5 to 50 mM for 12, 24, or...
<p>MCF7 (<b>A</b>) and MDAMB231 (<b>B</b>) cells were treated with metformin in DMEM without glucose...
<p>(A) MDA-MB-231 cells were treated with 5 mM metformin and 600 μM 2-DG in low-glucose (1 g/L) RPMI...
Cancer cells exhibit altered metabolism, a phenomenon described a century ago by Otto Warburg. Howev...
<p><b><i>A</i></b>, Single-cell suspensions of PANC-1 cells were plated at a density of 10<sup>5</su...